RadNet Reports Record Q1 Results, Boosts Full-Year Imaging Center Guidance
RDNT sits 21% above its 52-week low of $50.76.
Summary
RadNet reported record first-quarter 2026 financial results, driven by strong growth in both its imaging center and digital health segments, leading to an upward revision of its full-year guidance.
Key Events · Earnings and Guidance · RDNT
-
Record Q1 Financial Performance
Total company revenue increased 22.1% to $575.6 million, and Adjusted EBITDA rose 36.3% to $63.3 million compared to the first quarter of 2025.
-
Full-Year Guidance Raised
RadNet increased its 2026 guidance ranges for Imaging Center revenue, Adjusted EBITDA, and Free Cash Flow, reflecting strong operating trends.
-
Digital Health Segment Growth
The Digital Health segment saw revenue jump 51.5% to $29.1 million, with Annual Recurring Revenue (ARR) nearly doubling to $96.9 million at March 31, 2026.
-
Strategic Expansion and Partnerships
The company announced a new health system joint venture with Trinity Health's Saint Alphonsus Health System and highlighted the integration of the recently acquired Gleamer SAS.
Analysis · RDNT · Industrial Applications And Services
RadNet delivered strong first-quarter 2026 financial results, exceeding prior year performance with significant revenue and Adjusted EBITDA growth. Crucially, the company raised its full-year 2026 guidance for its Imaging Center segment across revenue, Adjusted EBITDA, and free cash flow, signaling increased confidence in its core business outlook. The Digital Health segment also demonstrated robust growth, further bolstered by the recent Gleamer acquisition and new joint ventures, positioning the company for continued expansion in AI-powered radiology solutions.
At the time of this filing, RDNT was trading at $61.49 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $4.6B. The 52-week trading range was $50.76 to $85.84. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.